Raleigh Capital Management Inc. Has $311,000 Stock Position in Danaher Co. (NYSE:DHR)

Raleigh Capital Management Inc. cut its position in Danaher Co. (NYSE:DHR) by 5.9% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 1,353 shares of the conglomerate’s stock after selling 85 shares during the quarter. Raleigh Capital Management Inc.’s holdings in Danaher were worth $311,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the company. Coronation Fund Managers Ltd. grew its position in Danaher by 29.9% during the 2nd quarter. Coronation Fund Managers Ltd. now owns 6,389 shares of the conglomerate’s stock worth $1,596,000 after acquiring an additional 1,470 shares during the last quarter. Public Sector Pension Investment Board boosted its stake in Danaher by 119.8% in the second quarter. Public Sector Pension Investment Board now owns 19,503 shares of the conglomerate’s stock worth $4,873,000 after purchasing an additional 10,628 shares in the last quarter. APG Asset Management US Inc. grew its holdings in shares of Danaher by 4.4% during the second quarter. APG Asset Management US Inc. now owns 211,565 shares of the conglomerate’s stock worth $51,730,000 after purchasing an additional 8,908 shares during the last quarter. APG Asset Management N.V. increased its stake in shares of Danaher by 13.6% in the second quarter. APG Asset Management N.V. now owns 531,544 shares of the conglomerate’s stock valued at $123,915,000 after buying an additional 63,712 shares in the last quarter. Finally, Daymark Wealth Partners LLC raised its holdings in shares of Danaher by 3.0% in the second quarter. Daymark Wealth Partners LLC now owns 16,498 shares of the conglomerate’s stock valued at $4,122,000 after buying an additional 485 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Danaher Stock Performance

NYSE:DHR opened at $245.73 on Friday. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. Danaher Co. has a twelve month low of $225.42 and a twelve month high of $281.70. The company has a fifty day moving average of $234.90 and a 200-day moving average of $253.47. The firm has a market capitalization of $177.49 billion, a P/E ratio of 46.90, a P/E/G ratio of 4.43 and a beta of 0.83.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. During the same quarter in the prior year, the company earned $2.02 earnings per share. The company’s quarterly revenue was up 3.1% on a year-over-year basis. As a group, sell-side analysts anticipate that Danaher Co. will post 7.5 EPS for the current year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be paid a dividend of $0.27 per share. The ex-dividend date is Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.44%. Danaher’s dividend payout ratio (DPR) is currently 20.61%.

Wall Street Analyst Weigh In

DHR has been the subject of a number of research reports. Guggenheim started coverage on shares of Danaher in a report on Thursday, December 19th. They issued a “buy” rating and a $275.00 price target for the company. Robert W. Baird dropped their target price on Danaher from $278.00 to $277.00 and set an “outperform” rating for the company in a research report on Wednesday, October 23rd. Citigroup cut their price target on Danaher from $305.00 to $285.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. StockNews.com cut Danaher from a “buy” rating to a “hold” rating in a report on Saturday, December 14th. Finally, Bank of America raised shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 target price on the stock in a research note on Friday, December 13th. Six research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $285.55.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.